CRYOPORT, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2018-12-31: Federal exemption Rule 506(b); Types of securities offered Equity; Convertible Notes; Date of first sale 2018-12-14; Total offering amount $25,000,000.
- 2018-12-28: Federal exemption Rule 506(b); Types of securities offered Equity; Convertible Notes; Date of first sale 2018-12-14; Total offering amount $25,000,000.
- 2016-04-20: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2016-04-07; Total offering amount $2,525,746.
- 2016-03-15: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2016-03-01; Total offering amount $46,156.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2018-12-31 D/A | Rule 506(b) | Equity; Convertible Notes | 2018-12-14 | $25,000,000 | $25,000,000 | $0 | 1 |
| 2018-12-28 | Rule 506(b) | Equity; Convertible Notes | 2018-12-14 | $25,000,000 | $25,000,000 | $0 | 1 |
| 2016-04-20 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired | 2016-04-07 | $2,525,746 | $2,525,746 | $0 | 192 |
| 2016-03-15 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired | 2016-03-01 | $46,156 | $46,156 | $0 | 3 |
| 2015-03-03 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2015-02-19 | $4,800,000 | $50,000 | $4,750,000 | 1 |
| 2014-05-16 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2014-05-06 | $9,600,000 | $1,584,173 | $8,015,827 | 32 |
| 2013-12-20 | Rule 506(b) | Debt; OptionToAcquire | 2013-12-06 | $1,000,000 | $305,000 | $695,000 | 7 |
| 2013-10-11 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2013-09-27 | $4,127,202 | $4,127,202 | $0 | 75 |
| 2012-05-25 | Rule 506 | Equity; OptionToAcquire; SecurityToBeAcquired | 2012-02-22 | $5,212,655 | $5,212,655 | $0 | 83 |
| 2011-02-24 | Rule 506 | Equity; OptionToAcquire; SecurityToBeAcquired | 2011-02-04 | $11,000,000 | $9,353,462 | $1,646,538 | 131 |
| 2010-10-28 D/A | Rule 506 | Equity; OptionToAcquire; SecurityToBeAcquired | 2010-08-20 | $7,500,000 | $3,872,702 | $3,627,298 | 60 |
| 2010-09-08 | Rule 506 | Equity; OptionToAcquire; SecurityToBeAcquired | 2010-08-20 | Indefinite | $3,289,701 | Indefinite | 44 |
| 2009-06-29 D/A | Rule 506 | Debt; OptionToAcquire; SecurityToBeAcquired | 2009-03-31 | $1,500,000 | $964,500 | $535,500 | 25 |
| 2009-06-19 D/A | Rule 506 | Debt; OptionToAcquire; SecurityToBeAcquired | 2009-03-31 | $1,500,000 | $964,500 | $535,500 | 25 |
| 2009-05-13 | Rule 506 | Debt; OptionToAcquire; SecurityToBeAcquired | 2009-03-31 | $1,000,000 | $370,000 | $630,000 | 8 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |